Figures computed from official regulatory filings — .
Analysttarget 14 USD (+44%)
Ownershipinsiders 32% · institutions 20.45% · short 0.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for IMMUCELL CORP /DE/ only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
377 buys32 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| te Boekhorst Paul Francis Oliviertrack record | Buy | $76K | conv 76 |
| SEC |
| Basse Gloria F | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tomsche David Scotttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wainman Paul Rtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Turner Kathy V | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kunde Bobbi Jo | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wainman Paul Rtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gathagan Bryan K. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Basse Gloria F | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC |
| Tomsche David Scotttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC |
| Rosgen Steven T. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC |
| BRIGHAM MICHAEL Ftrack record | Exercise | $146K | Unusual size | SEC |
| BRIGHAM MICHAEL Ftrack record | Other | $146K | Unusual size | SEC |
| BRIGHAM MICHAEL Ftrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| te Boekhorst Paul Francis Oliviertrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fiori Timothy C | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kunde Bobbi Jo | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| te Boekhorst Paul Francis Oliviertrack record | Buy | $18.2K | conv 76 | SEC |
| te Boekhorst Paul Francis Oliviertrack record | Buy | $13.4K | conv 45 | SEC |
| te Boekhorst Paul Francis Oliviertrack record | Buy | $12.8K | conv 69 | SEC |
| te Boekhorst Paul Francis Oliviertrack record | Buy | $17.7K | conv 66 | SEC |
| te Boekhorst Paul Francis Oliviertrack record | Buy | $18.1K | conv 80First in 12mo | SEC |
| Tomsche David Scotttrack record | Buy | $7.8K | conv 56First in 12mo | SEC |
| Tomsche David Scotttrack record | Buy | $7.8K | conv 42First in 12mo | SEC |
| te Boekhorst Paul Francis Oliviertrack record | AwardD (derivative) | $453.1K | SEC |